These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 4831715

  • 1. [Comparative study of the vasoconstrictive activity of preparations containing topical corticosteroids].
    Henschel V, Jaminet F.
    J Pharm Belg; 1974; 29(1):3-15. PubMed ID: 4831715
    [No Abstract] [Full Text] [Related]

  • 2. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
    Borelli C, Gassmueller J, Fluhr JW, Nietsch KH, Schinzel S, Korting HC.
    Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
    [Abstract] [Full Text] [Related]

  • 3. Factors influencing the formulation of semisolid preparations with special reference to corticosteroid products.
    Worthington HE.
    Acta Derm Venereol Suppl (Stockh); 1973; 53():29-34. PubMed ID: 4518660
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of corticosteroids intended for use as topical anti-inflammatory drugs.
    Bagatell FK, Augustine MA.
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):748-57. PubMed ID: 4210465
    [No Abstract] [Full Text] [Related]

  • 5. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
    Meyer E, Smith EW, Haigh JM, Kanfer I.
    Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
    [Abstract] [Full Text] [Related]

  • 6. [Comparative testing of a new cream-base against unguentum diachylon in ulcus cruris].
    Klostermann GF, Jakob H.
    MMW Munch Med Wochenschr; 1974 Jun 07; 116(23):1169-70. PubMed ID: 4212590
    [No Abstract] [Full Text] [Related]

  • 7. [Penetration kinetics of topical steroids].
    Tronnier H.
    Arch Klin Exp Dermatol; 1970 Jun 07; 237(3):769-73. PubMed ID: 5523569
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of atrophy production and vasoconstrictor potency in humans following intradermally injected corticosteroids.
    Snyder DS, Greenberg RA.
    J Invest Dermatol; 1974 Dec 07; 63(6):461-3. PubMed ID: 4430856
    [No Abstract] [Full Text] [Related]

  • 9. Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay.
    Woodford R, Barry BW.
    Curr Ther Res Clin Exp; 1974 Apr 07; 16(4):338-45. PubMed ID: 4208350
    [No Abstract] [Full Text] [Related]

  • 10. [Testing the loss of efficacy (tachyphylaxis) during external steroid application].
    Koch EM, Jurgovsky E.
    Hautarzt; 1985 Mar 07; 36(3):146-9. PubMed ID: 3997512
    [Abstract] [Full Text] [Related]

  • 11. Animal studies with topical steroids.
    Weidmann H.
    Acta Derm Venereol Suppl (Stockh); 1973 Mar 07; 53():25-7. PubMed ID: 4518659
    [No Abstract] [Full Text] [Related]

  • 12. [Comparison of the efficiency of various externally used corticosteroids].
    Horácek J, Semrádová V.
    Z Hautkr; 1974 Jul 01; 49(13):555-8. PubMed ID: 4423320
    [No Abstract] [Full Text] [Related]

  • 13. Effect of short-term administration of synthetic corticosteroids on pituitary-adrenal function.
    Fotherby K, Warren RJ, Harcus AW.
    Arzneimittelforschung; 1974 Jan 01; 24(1):97-9. PubMed ID: 4406120
    [No Abstract] [Full Text] [Related]

  • 14. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
    Weirich EG, Lutz U.
    Dermatologica; 1973 Jan 01; 147(6):353-75. PubMed ID: 4788215
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC, Greif C, Metzner U, Wigger-Alberti W, Elsner P.
    Skin Pharmacol Physiol; 2007 Jan 01; 20(3):133-40. PubMed ID: 17191036
    [Abstract] [Full Text] [Related]

  • 16. Influence of corticosteroid on recovery from oxygen toxicity.
    Sahebjami H, Gacad G, Massaro D.
    Am Rev Respir Dis; 1974 Nov 01; 110(5):566-71. PubMed ID: 4429252
    [No Abstract] [Full Text] [Related]

  • 17. Plethysmographic recordings of skin pulses. IV. The vasoconstrictive effect of steroids in normal and stripped skin.
    Thune P.
    Acta Derm Venereol; 1971 Nov 01; 51(4):261-7. PubMed ID: 4105772
    [No Abstract] [Full Text] [Related]

  • 18. Vasoconstrictor and systemic activities of topical steroids.
    Burdick KH, Child KJ, English AF, Gilbert HG, Hewitt A, Woollett EA.
    Arch Dermatol; 1968 Dec 01; 98(6):684-6. PubMed ID: 5697255
    [No Abstract] [Full Text] [Related]

  • 19. Topical therapy with fluorinated and non-fluorinated corticosteroids in patients with atopic dermatitis.
    Gregurek-Novak T.
    J Eur Acad Dermatol Venereol; 2001 Jan 01; 15(1):81-2. PubMed ID: 11451336
    [No Abstract] [Full Text] [Related]

  • 20. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. III. Vasoeffect of mineralocorticoids time slope of vasoconstriction influence of steroid concentration].
    Altmeyer P, Zaun H.
    Arch Dermatol Forsch; 1974 Jan 01; 250(4):381-8. PubMed ID: 4447379
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.